<DOC>
	<DOCNO>NCT00917644</DOCNO>
	<brief_summary>To determine whether new 80 mg atorvastatin tablet bioequivalent 80 mg commercial atorvastatin tablet ( LipitorÂ® ) .</brief_summary>
	<brief_title>Bioequivalence Study Comparing A New 80 Mg Atorvastatin Tablet To A 80 Mg Atorvastatin Commercial Tablet</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Healthy male and/or female subject age 18 55 year . Body Mass Index ( BMI ) 18 30 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) disease clinical finding screen . Treatment investigational drug within 30 day 5 half life precede first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Bioqeuivalence , Pharmacokinetics , Atorvastatin</keyword>
</DOC>